Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Gaush Meditech Ltd. ( (HK:2407) ) just unveiled an update.
Gaush Meditech Ltd announced that its subsidiary, Gaush Precision Ltd, has received a medical device registration certificate in China for its disposable ophthalmic trocar and accessories. This product is designed for vitrectomy surgeries, offering benefits such as no scleral deformation, exceptional sharpness, and faster recovery. The approval comes amid a rising incidence of fundus diseases in China, driven by an aging population and lifestyle changes, highlighting the product’s potential impact on the market.
More about Gaush Meditech Ltd.
Gaush Meditech Ltd, incorporated in the Cayman Islands, operates in the medical technology industry with a focus on developing innovative medical devices. A key subsidiary, Gaush Precision Ltd, specializes in ophthalmic products, particularly those used in eye surgeries.
Average Trading Volume: 123,518
Technical Sentiment Signal: Sell
Current Market Cap: HK$984.9M
Learn more about 2407 stock on TipRanks’ Stock Analysis page.